The vast complexity of native heteromeric K + channels is largely unexplored. Defining the composition and subunit arrangement of individual subunits in native heteromeric K + channels and establishing their physiological roles is experimentally challenging. Here we systematically explored this "zone of ignorance" in molecular neuroscience. Venom components, such as peptide toxins, appear to have evolved to modulate physiologically relevant targets by discriminating among closely related native ion channel complexes. We provide proof-of-principle for this assertion by demonstrating that κM-conotoxin RIIIJ (κM-RIIIJ) from Conus radiatus precisely targets "asymmetric" K v channels composed of three K v 1.2 subunits and one K v 1.1 or K v 1.6 subunit with 100-fold higher apparent affinity compared with homomeric K v 1.2 channels. Our study shows that dorsal root ganglion (DRG) neurons contain at least two major functional K v 1.2 channel complexes: a heteromer, for which κM-RIIIJ has high affinity, and a putative K v 1.2 homomer, toward which κM-RIIIJ is less potent. This conclusion was reached by (i) covalent linkage of members of the mammalian Shaker-related K v 1 family to K v 1.2 and systematic assessment of the potency of κM-RIIIJ block of heteromeric K + channel-mediated currents in heterologous expression systems; (ii) molecular dynamics simulations of asymmetric K v 1 channels providing insights into the molecular basis of κM-RIIIJ selectivity and potency toward its targets; and (iii) evaluation of calcium responses of a defined population of DRG neurons to κM-RIIIJ. Our study demonstrates that bioactive molecules present in venoms provide essential pharmacological tools that systematically target specific heteromeric K v channel complexes that operate in native tissues.
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I
on channels open to allow ion flow across an otherwise impermeable membrane. The functional channel protein may consist of a single α-subunit with multiple similarly organized domains (e.g., voltage-gated Na + and Ca 2+ channels) or by the assembly of monomeric α-subunits that associate noncovalently to form the functional pore. Thus, several homologous genes may encode the monomeric α-subunits that comprise a functional ion channel. Examples include TRP (transient receptor potential), K v (voltagegated potassium channels), and the ligand-gated channels. In these families, combinations of multiple α-subunit isoforms give rise to a vast array of functional channels.
More than 70 different genes encode mammalian K + channel α-subunits constituting the most diverse ion channel family with thousands of potential multimeric arrangements. A central question in integrating the molecular/cellular knowledge into systems neuroscience is which specific complexes of these diverse families are physiologically relevant?
The problem addressing this fundamental question is schematically illustrated in Fig. 1A . There, the combination of only two different K v 1 subunits produces six alternative channels with varying levels of functional specialization. Theoretically, the heteromerization of the seven members of the K v 1 family (K v 1.1-1.7) investigated here potentially generate hundreds of tetrameric complexes that are virtually indistinguishable in native tissues as the biophysical properties often overlap. The straightforward approach of ablating individual α-subunits (gene knockouts) would result in the functional deletion of all of the different complexes containing that subunit, complicating the interpretation of the resulting phenotypes.
A large body of literature suggests that most neuronal K v channels are in fact heteromeric combinations of one to four different α-subunits of loosely defined molecular identity. Here, we devised a neuropharmacological strategy to systematically dissect the contribution of single K v 1 α-subunits to heteromeric complexes by exploiting venom peptides that presumably evolved to alter prey behavior and appear "surgically" targeted to specific heteromeric K + channel complexes. We have examined the specificity of κM-conotoxin RIIIJ from the venom of piscivorous cone snail Conus radiatus, which was initially described as a K v 1.2 antagonist (1). The current study provides a thorough assessment of its activity against a variety of K v 1.2 containing heteromeric K v 1 channels. The potency and exquisite selectivity of κM-RIIIJ suggests that this peptide evolved to target asymmetrically arranged
Significance
Most ion channels are multimeric (typically comprising 3-5 subunits). The subunits are encoded by homologous members of a gene family, generating an enormous set of possible heteromeric combinations. In this study, we provide evidence that the preferred target of conopeptide κM-RIIIJ is a heteromeric K v 1 channel consisting of three K v 1.2 subunits and one K v 1.1 or K v 1.6 subunit. We define the molecular interaction of κM-RIIIJ with these asymmetric K v 1 channels and show that in dorsal root ganglia (DRG) neurons, different κM-RIIIJ concentrations can distinguish discrete subpopulations of neurons. Our results highlight the potential of natural products and venom components, such as conopeptides, to generally elucidate native physiological roles of specific heteromeric ion channel isoforms at the cellular, circuit, and systems level.
heteromeric K v channels instead of the symmetric K v 1.2 homomer as previously reported.
Thus, this study has important general implications: if natural products like venom-derived peptides evolved to target native voltage-gated K + channels, their highest-affinity targets may well be heteromeric combinations. Accordingly, naturally evolved K + channel-targeted ligands like κM-RIIIJ may be key to determining the composition and function of heteromeric voltagegated K + channels in biological systems.
Results
κM-RIIIJ Preferentially Targets Heteromeric K v Channels.
Block of homomeric K v 1 channels. As previously noted, assessing the vast diversity of potential K v 1 channel combinations is a formidable endeavor, as represented by the schematic (Fig. 1A) . This suggests that reversing order of monomers within these heterodimers yields similar binding surfaces for the κM-RIIIJ. Similarly, K v 1.2/1.5 dimers were blocked slightly less potently than those formed by K v 1.5/ 1.2 (287 ± 163 nM, n = 3, vs. 99 ± 11 nM, n = 4, respectively), suggesting κM-RIIIJ's minimal ability to distinguish between these two different arrangements. Furthermore, κM-RIIIJ displayed modest block of heterodimers of K v 1.2/1.4 and K v 1.4/ 1.2 (IC 50 : 8.1 ± 2 μM, n = 3 and 1.6 ± 2.6 μM, n = 5, respectively), similar to the homomeric channel screen. iii) In striking contrast, the apparent affinity of κM-RIIIJ for heterodimers K v 1.2/1.1 (14.3 ± 2.6 nM, n = 7) and K v 1.1/1.2 (18.4 ± 6 nM, n = 10) was significantly increased in comparison with their homotetramers. Similarly, the heterodimeric K v 1.2/ 1.6 and K v 1.6/1.2 were strongly blocked by κM-RIIIJ with IC 50 s of 8.7 ± 2.1 nM (n = 14) and 6.1 ± 1.7 nM (n = 9). Thus, the apparent affinity of κM-RIIIJ toward heterodimers containing K v 1.2 is greatly influenced by the subunit composition in the heterodimeric complexes. Furthermore, the observed increase in the apparent affinity of κM-RIIIJ for some of the channels generated as linked concatemers provides a functional readout implying their correct assembly in the plasma membrane.
In summary, heterodimerization of K v 1.3-5 and K v 1.7 α-subunits with K v 1.2 results in ∼10-fold increase in κM-RIIIJ's apparent affinity for the complex. Most dramatically, K + currents mediated by dimers of K v 1.2 with either K v 1.1 or K v 1.6 are blocked >100-fold more potently than those flowing through their homomeric counterparts. Block of K v 1 "asymmetric" heterotetramers. The higher affinity of κM-RIIIJ for heterodimeric K v 1.2/K v 1.1 and K v 1.2/K v 1.6 channels, relative to their homomeric counterparts, demonstrates that relatively small differences in the binding surface of the target channel are critical to κM-RIIIJ's activity. Functional K v channels are formed by four independent α-subunits; therefore, a binomial arrangement of two α-subunits will have any of those subunits occupying any position of the tetramer. Thus, "symmetric" (2:2 = AABB or ABAB) or "asymmetric" channels composed of 3xA and 1xB (and vice versa) are possible. This flexibility would result in significantly different molecular recognition surfaces exposed to peptide toxins like κM-RIIIJ, which we set out to explore by generating binomial concatemers of K v 1.2 and either K v 1.1 or K v 1.6, in 2:2 and 3:1 stoichiometry, and linked in different orders. The correct and complete synthesis of the constructs used throughout this work was verified by immunodetection by an anti-K v 1.2 antibody in Western blot experiments. Fig. 2A shows an experiment, in which the protein products of representative constructs expressed in HEK293 cells were electrophoresed and immunoblotted. In this figure, clear bands at 75, 150, and 300 kDa report on monomeric, dimeric, and tetrameric channels, respectively, of expected molecular weight, as each homomer is ∼75 kDa. The bar graph in Fig. 2C condenses our analysis of symmetric and asymmetric channels exposed to conotoxin κM-RIIIJ. The equal inhibition of symmetric K v 1.6/1.2/1.6/1.2 and K v 1.6/1.2/1.2/ 1.6 channels (IC 50 : 13.6 ± 3.6 nM, n = 4 and 15.9 ± 4.2 nM, n = 3, respectively) shows that the "order" of the two subunits does not alter κM-RIIIJ binding. In contrast, analysis of the tetrameric concatemers that presented an asymmetric surface (3:1 stoichiometry) revealed that such configuration was determinant to high-affinity κM-RIIIJ binding. Hence, the apparent affinity of κM-RIIIJ for K v 1.1/1.2/1.2/1.2 channels was 1.2 ± 0.3 nM (n = 8), while only 0.5 ± 0.1 nM (n = 14) κM-RIIIJ was sufficient to block 50% of the K v 1.6/1.2/1.2/1.2 mediated currents ( Fig. 2 B and C) . These results demonstrate that the apparent affinity of κM-RIIIJ for heteromeric Kv1 channels consisting of K v 1.2 and either K v 1.1 or K v 1.6 is higher when the tetrameric channel contains only one subunit of either K v 1.1 or K v 1.6 as opposed to two. This shows that although the apparent affinity to homomers of K v 1.1 or K v 1.6 is lower by one order of magnitude compared with those of K v 1.2, the sole presence of one such subunit, either K v 1.1 or K v 1.6, is sufficient to cause a >100-fold enhancement in the affinity of κM-RIIIJ for the K v 1 complex. The observed increased sensitivity of the linked concatemeric proteins to κM-RIIIJ provides a functional readout of their correct assembly in the plasma membrane.
Furthermore, these findings show that the asymmetric surface of K v s composed of three K v 1.2 and one K v 1.1/K v 1.6 is highly favorable to κM-RIIIJ binding. Thus, the graded effects of κM-RIIIJ are an accurate correlate to the channel composition and stoichiometry, representing a valuable tool in the study of neuronal voltage-gated K v channels.
Molecular Insights into κM-RIIIJ Binding to Asymmetric Kv1 Heteromers.
Functionally, inclusion of one subunit of either K v 1.1 or K v 1.6 leads to a profound increase in κM-RIIIJ's affinity for K v 1.2-containing channels. Sequence alignment of the Shaker and Kv1 pore regions is shown in Fig. 3A . Visual inspection reveals that K v 1.1 and K v 1.6 distinguish themselves from the other K v 1s in that a tyrosine (Y379 and Y429, respectively) resides in the homologous position of Shaker T449, known to be critical for extracellular binding of several substances including tetraethylammonium (2) . Previous studies on κM-RIIIK (a close relative of κM-RIIIJ) described it as a poreblocking peptide (3) (4) (5) , and therefore we surmised κM-RIIIJ would exert its inhibitory actions by interacting with the same channel region. Hence, a tyrosine residue was introduced in the homologous position of K v 1.4 (K531Y) within the heterodimer K v 1.2/K v 1.4, and the reciprocal mutation was made in K v 1.6 in K v 1.2/K v 1.6. Fig. 3B provides examples of current traces of the wild-type and pore mutant dimers K v 1.2/K v 1.4-K531Y and K v 1.2/ K v 1.6-Y429K. Exposure to 10 nM κM-RIIIJ (red) clearly highlights the importance of such tyrosine within the heteromeric pores. Thus, K v 1.2/K v 1.4-K531Y is blocked with an IC 50 of 9 ± 0.7 nM (n = 5), in stark contrast with its wild-type counterpart (8.1 ± 2 μM, n = 5). Accordingly, the mutant heterodimer K v 1.2/ K v 1.6-Y429K significantly lost sensitivity to κM-RIIIJ (IC 50 2.0 ± 0.2 μM, n = 4). Thus, an apparent affinity increase of ∼1,000-fold for K v 1.2/K v 1.4-K531Y and the ∼250-fold decrease in binding affinity for K v 1.2/K v 1.6-Y429K demonstrate that (i) a tyrosine residue within the heteromeric pore is a major determinant of κM-RIIIJ's potency; and (ii) κM-RIIIJ intimately interacts with the K v channel pore.
Introducing the equivalent K/Y mutation in the asymmetric K v 1.2/1.2/1.2/1.4 concatemer results in 200-fold higher affinity of κM-RIIIJ for K v 1.2/1.2/1.2/1.4-K531Y channels, corroborating the crucial role of this amino acid for peptide-binding strength to asymmetric channel complexes (SI Appendix, Fig. S1) .
A global perspective of κM-RIIIJ association with asymmetric heterotetramers was obtained by molecular dynamics simulations. For this, the biological assembly of K v 1.2's crystal structure (3LUT, pore residues 311-421) served as a template where the asymmetry-imposing subunits (K v 1.6 and K v 1.1) were Table S2 ).
homology-modeled and incorporated. The structure of κM-RIIIJ was based on similarity to κM-RIIIK (Methods), and interaction to K v 1.6/1.2/1.2/1.2 and K v 1.1/1.2/1.2/1.2 was assessed in silico. As depicted in Fig. 3C , molecular dynamic simulation returned three major clusters (29-14% likelihood, Top) where the likely orientation of κM-RIIIJ within the asymmetric pore indicates that lysine 9 (from κM-RIIIJ) orients itself into the channel's permeation pathway. Fig. 3A) , which may exert repulsive forces over the toxin's positively charged moieties. As shown by the electrophysiological experiments, eliminating the charge of this position in heterodimeric and tetrameric constructs restores the toxin affinity for the heteromeric constructs, further underpinning the significance of electrostatic interactions in κM-RIIIJ binding.
κM-RIIIJ Distinguishes Between DRG Neuron Subtypes. Sensory neurons in the dorsal root ganglia (DRG) express various members of the K v 1 family of K + channels. However, the functional and pharmacological similarities between homomeric K + channels mediated by close family relatives like K v 1.1, K v 1.2, and K v 1.6 has hindered the assignment of precise molecular correlates to the native currents observed in DRGs. An exquisitely tuned peptide like κM-RIIIJ provides the opportunity to distinguish neurons in which homo-or heteromeric K v 1 channel populations are expressed, based on their sensitivity to this conotoxin. We took advantage of the high-content Ca 2+ -imaging approach known as constellation pharmacology (6, 7) to explore the question posed. Fig. 4 provides a snapshot of one such experiment, in which dissociated mouse DRG neurons were loaded with Fura-2-AM and subjected to various concentrations of κM-RIIIJ and the K v 1.1-selective blocker, Dtx-K, before depolarizing stimuli. Therefore, we can postulate that this medium-diameter DRG neuronal cell population expresses K v 1.1/1.2 heteromeric channels. Furthermore, the Ca 2+ responses shown in Fig. 4C were obtained from small (each had a cross-sectional cell area ∼250 μm 2 ) DRG cells that only responded to the high dose of κM-RIIIJ suggesting a population where Kv1.2 homotetramers or low-affinity heterotetramers are the dominant channels expressed.
Discussion
The physiological role of heteromeric K v channels has rarely been explored due to the lack of reliable pharmacological tools. From the multiple cone snail toxins that interact with K v channels, κM-RIIIJ was shown to interact with homomeric K v 1.2 channels in Xenopus oocytes. Here, we offer evidence of κM-RIIIJ's preferential (>100-fold) inhibition of heteromeric channels composed of three K v 1.2 and one K v 1.1 or K v 1.6 α-subunits. We have identified crucial molecular interactions between κM-RIIIJ and the K v 1 channel pore that provide a rationale for the exquisite selectivity and potency of κM-RIIIJ for asymmetric K v 1 heteromers. Finally, use of κM-RIIIJ in constellation pharmacology (6, 7) experiments pinpointed identifiable subpopulations of mouse DRG neurons with distinct functional K v 1.2-containing channel subsets.
Heteromeric K v Channels. Although different K v 1 subunits have been identified in various cell types, most studies rely on immunodetection of channel proteins or mRNA (qPCR, hybridization probes), which do not provide accurate information about the actual composition of multisubunit complexes like heteromeric K v 1 channels at the single-cell level. In the CNS, several heteromeric combinations of K v 1.2 with either K v 1.1 or K v 1.6 have been proposed. An elegant but laborious immunoprecipitation study used antibodies to systematically deplete individual K v subunits from tissue homogenates, revealing the presence of multiple heteromeric K v channels in the human CNS (8) . In this study, the existence of K v 1.1/K v 1.2 heteromeric channels in cortical gray matter, white matter, and spinal cord (8) Little is known about heteromeric K v 1 complexes in nonneuronal tissue and, particularly, in the heart the functional importance of heteromeric K v 1s has received little attention. A previous report from our laboratory showed that, unlike κM-RIIIJ, κM-RIIIK is cardioprotective in a rodent model of ischemia/reperfusion, despite its comparatively weaker block of homomeric K v 1.2 (1) . Differential activity of these peptides on K v 1.2 heterodimeric channels provided a plausible explanation for disparate effects in such closely related peptides. The results presented in this study corroborate our previous findings in that the higher-affinity targets of κM-RIIIJ are composed of subunits not abundantly found in cardiomyocytes [for overview, see Nerbonne and Kass (12)]. Curiously, K v 1.1, K v 1.2, and K v 1.6 have been immunodetected in sinoatrial node cells in ferret hearts (13) .
Our data suggest that the likely "natural" targets of κM-RIIIJ actions are neurons containing K v 1.2/K v 1.1 or K v 1.2/K v 1.6 heteromers, which would be congruent with the potential role of κM-RIIIJ in prey capture as a part of the "lightning strike cabal" (14) . Our experiments identifying different subpopulations of DRG neurons by their responses to either low or high [κM-RIIIJ] strongly support the notion of K v 1.2 subunits as part of heteroand homomeric K + channels in the peripheral nervous system.
It is remarkable that κM-RIIIJ preferentially inhibits asymmetric K v channels with 1:3 stoichiometry.
Other channel families that assemble in tetramers composed of two related subunits in 3:1 stoichiometry may be of physiological importance. Such is the case of the modulatory K v α-subunit K v 9.3, which does not form functional homotetramers, but participates in heteromeric arrangements of 3xK v 2.1 and 1xK v 9.3 subunits (15) . The molecular determinants of heteromeric cyclic nucleotide-gated (CNG) channels of 3xCNGA1 and 1xCNGB1 have been described elsewhere (16, 17) . Thus, it is plausible to anticipate that many other heteromeric K + channels of asymmetric composition exist in nature. This would imply that such nonsymmetric arrangement of functional channels delineates a correspondingly asymmetric permeation pathway of significant pharmacological standing. In line with our findings, previous work showed that the affinity of TEA to Kv1.1/Kv1.2 concatemers is affected by the subunit ratio (18) . Therefore, asymmetric ion channel compositions should be taken into account in the development of K v channel-targeted substances of therapeutic potential.
κM-RIIIJ: A Tool for the Study of Heteromeric Kv1 Channels. Our work in heterologous systems underpins the potential of κM-conotoxin RIIIJ as a valuable diagnostic tool for the identification of functional K v 1 channel complexes according to their sensitivity to this conotoxin. We verified κM-RIIIJ's ability to distinguish among peripheral neuron subclasses expressing distinct heteromeric K v channels by constellation pharmacology. We used the K v 1.1-selective blocker Dendrotoxin-K to identify DRG neuronal cells in which heteromeric channels formed by K v 1.1 and K v 1.2 constitute a major component of the I KDR in these cells. Results presented throughout this paper highlight the advantages of using conotoxins and, particularly, κM-RIIIJ, as pharmacological tools to enable the study of functioning heteromeric K v channels in living cells.
Materials and Methods
Conotoxin κM-RIIIJ was synthesized as described by Chen et al. (1) . The K v 1 channels used here correspond to the human isoforms: K v 1.1 (hKCNA1; NM_000217), K v 1.2 (hKCNA2; NM_004974), K v 1.3 (hKCNA3; NM_002232), K v 1.4 (hKCNA4; NM_002233), K v 1.5 (hKCNA5; NM_002234), K v 1.6 (hKCNA6; NM_002235), and K v 1.7 (hKCNA7; NM_031886).
Molecular Biology. cDNAs coding hK v 1.1-7 α-subunits were subcloned into pcDNA3.1 for expression in HEK293 cells. Dimeric concatenated K v 1 subunits were generated by replacement of the stop (anterior subunit) and start codons (posterior subunit) by AatII restriction sites according to the QuikChange Site directed Mutagenesis method (Stratagene). Tetrameric concatemers were built by fusion of dimeric constructs, in which the stop (anterior dimer) and start codons (posterior dimer) were replaced by an XhoI restriction site. All constructs were verified by sequencing.
Cell Culture and Electrophysiological Recordings. All electrophysiological measurements were done with transiently transfected HEK293 cells in the whole-cell configuration of the patch-clamp technique at room temperature. For more detail, see SI Appendix, Supplementary Methods.
